Guangxiang Luo

5.8k total citations
75 papers, 4.3k citations indexed

About

Guangxiang Luo is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Guangxiang Luo has authored 75 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hepatology, 38 papers in Epidemiology and 21 papers in Molecular Biology. Recurrent topics in Guangxiang Luo's work include Hepatitis C virus research (43 papers), Hepatitis B Virus Studies (20 papers) and Liver Disease Diagnosis and Treatment (15 papers). Guangxiang Luo is often cited by papers focused on Hepatitis C virus research (43 papers), Hepatitis B Virus Studies (20 papers) and Liver Disease Diagnosis and Treatment (15 papers). Guangxiang Luo collaborates with scholars based in United States, China and Germany. Guangxiang Luo's co-authors include Jieyun Jiang, Zhaohui Cai, Kyung-Soo Chang, Richard J. Colonno, Nazira El‐Hage, Mark Krystal, Wei Cun, Qing Shi, Wei Yang and Hengli Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Guangxiang Luo

75 papers receiving 4.3k citations

Peers

Countries citing papers authored by Guangxiang Luo

Since Specialization

Citations

This map shows the geographic impact of Guangxiang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangxiang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangxiang Luo more than expected).

Fields of papers citing papers by Guangxiang Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangxiang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangxiang Luo. The network helps show where Guangxiang Luo may publish in the future.

Co-authorship network of co-authors of Guangxiang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Guangxiang Luo. A scholar is included among the top collaborators of Guangxiang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangxiang Luo. Guangxiang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection 2021 ·PLoS Pathogens ·Yingying Li, Guangxiang Luo	24
2	Zika virus NS5 nuclear accumulation is protective of protein degradation and is required for viral RNA replication 2019 ·Virology ·Wei Ji, Guangxiang Luo	26
3	Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis 2018 ·Virology ·Han Zhang, (unknown), Guangxiang Luo	4
4	Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a 2016 ·The Journal of Microbiology ·(unknown), Hye-Ran Kim, Gyunam Park, Guangxiang Luo, Kyung-Soo Chang	1
5	Apolipoprotein E Mediates Attachment of Clinical Hepatitis C Virus to Hepatocytes by Binding to Cell Surface Heparan Sulfate Proteoglycan Receptors 2013 ·PLoS ONE ·Jieyun Jiang, Xianfang Wu, Hengli Tang, Guangxiang Luo	49
6	Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules 2012 ·Virology ·Cara T. Pager, Sylvia Schütz, (unknown), Guangxiang Luo, Peter Sarnow	65
7	Transient Activation of the PI3K-AKT Pathway by Hepatitis C Virus to Enhance Viral Entry 2012 ·Journal of Biological Chemistry ·Zhe Liu, Yongjun Tian, Keigo Machida, Michael M. C. Lai, Guangxiang Luo, Steven K. H. Foung, Jing‐hsiung James Ou	76
8	Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy 2012 ·Autophagy ·He Huang, (unknown), Ji Wang, Guangxiang Luo, Wei Yang, Zhendong Zhao	119
9	Recent advance in antiviral drugs for hepatitis C. 2011 ·PubMed ·Jia Liu, Shuang Shi, Hui Zhuang, Guangxiang Luo	2
10	Hepatitis C Virus Core-Derived Peptides Inhibit Genotype 1b Viral Genome Replication via Interaction with DDX3X 2010 ·PLoS ONE ·Chaomin Sun, Cara T. Pager, Guangxiang Luo, Peter Sarnow, J.H.D. Cate	19
11	Apolipoprotein E Interacts With Hepatitis C Virus Nonstructural Protein 5A and Determines Assembly of Infectious Particles 2009 ·Hepatology ·(unknown), Sophie Krieger, Maria Dimitrova, Mirjam B. Zeisel, (unknown), Joachim Lupberger, Eberhard Hildt, Guangxiang Luo, John McLauchlan, Thomas F. Baumert, Catherine Schuster	179
12	Proteomics Study of the Hepatitis C Virus Replication Complex 2009 ·Methods in molecular biology ·Kyung-Soo Chang, Tianyi Wang, Guangxiang Luo	3
13	Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production 2008 ·Hepatology ·Wei Yang, Brian L. Hood, (unknown), Shufeng Liu, Simon C. Watkins, Guangxiang Luo, Thomas P. Conrads, Tianyi Wang	158
14	Heterologous RNA replication enhancer stimulates in vitro RNA synthesis and template-switching by the carmovirus, but not by the tombusvirus, RNA-dependent RNA polymerase: Implication for modular evolution of RNA viruses 2005 ·Virology ·Chi‐Ping Cheng, Tadas Panavas, Guangxiang Luo, Peter D. Nagy	33
15	Retrospective analysis of non‐A–E hepatitis: Possible role of hepatitis B and C virus infection 2002 ·Journal of Medical Virology ·Zhongping He, Hui Zhuang, Xiaohong Wang, Shujing Song, Qingming Dong, (unknown), Gertrude Case Buehring, Guangxiang Luo	19
16	Structure–activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-Trimethyl-5-hydroxy-cyclohexylmethylamine 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Albert Torri, Guangxiang Luo, Christopher Cianci, (unknown), (unknown), (unknown), Mark Krystal, Nicholas A. Meanwell	44
17	An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology 2001 ·Bioorganic & Medicinal Chemistry Letters ·Milind Deshpande, Jianmei Wei, Guangxiang Luo, Christopher Cianci, (unknown), Al F. Torri, Laurence Tiley, Mark Krystal, (unknown), Stella Huang, Qi Gao, Nicholas A. Meanwell	27
18	Cellular Proteins Bind to the Poly(U) Tract of the 3′ Untranslated Region of Hepatitis C Virus RNA Genome 1999 ·Virology ·Guangxiang Luo	47
19	Inhibition of influenza viral polymerases by minimal viral RNA decoys. 1997 ·Journal of General Virology ·Guangxiang Luo, (unknown), Mark Krystal	10
20	Genetic analysis of influenza virus 1992 ·Current Opinion in Genetics & Development ·Guangxiang Luo, Peter Palese	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact